Skip to main content

The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP.

Publication ,  Journal Article
Umano, A; Fang, K; Qu, Z; Scaglione, JB; Altinok, S; Treadway, CJ; Wick, ET; Paulakonis, E; Karunanayake, C; Chou, S; Bardakjian, TM; Page, RC ...
Published in: J Biol Chem
May 2022

The spinocerebellar ataxias (SCAs) are a class of incurable diseases characterized by degeneration of the cerebellum that results in movement disorder. Recently, a new heritable form of SCA, spinocerebellar ataxia type 48 (SCA48), was attributed to dominant mutations in STIP1 homology and U box-containing 1 (STUB1); however, little is known about how these mutations cause SCA48. STUB1 encodes for the protein C terminus of Hsc70 interacting protein (CHIP), an E3 ubiquitin ligase. CHIP is known to regulate proteostasis by recruiting chaperones via a N-terminal tetratricopeptide repeat domain and recruiting E2 ubiquitin-conjugating enzymes via a C-terminal U-box domain. These interactions allow CHIP to mediate the ubiquitination of chaperone-bound, misfolded proteins to promote their degradation via the proteasome. Here we have identified a novel, de novo mutation in STUB1 in a patient with SCA48 encoding for an A52G point mutation in the tetratricopeptide repeat domain of CHIP. Utilizing an array of biophysical, biochemical, and cellular assays, we demonstrate that the CHIPA52G point mutant retains E3-ligase activity but has decreased affinity for chaperones. We further show that this mutant decreases cellular fitness in response to certain cellular stressors and induces neurodegeneration in a transgenic Caenorhabditis elegans model of SCA48. Together, our data identify the A52G mutant as a cause of SCA48 and provide molecular insight into how mutations in STUB1 cause SCA48.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Biol Chem

DOI

EISSN

1083-351X

Publication Date

May 2022

Volume

298

Issue

5

Start / End Page

101899

Location

United States

Related Subject Headings

  • Ubiquitination
  • Ubiquitin-Protein Ligases
  • Ubiquitin
  • Spinocerebellar Ataxias
  • Mutation
  • Humans
  • Biochemistry & Molecular Biology
  • 34 Chemical sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Umano, A., Fang, K., Qu, Z., Scaglione, J. B., Altinok, S., Treadway, C. J., … Scaglione, K. M. (2022). The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP. J Biol Chem, 298(5), 101899. https://doi.org/10.1016/j.jbc.2022.101899
Umano, A., K. Fang, Z. Qu, J. B. Scaglione, S. Altinok, C. J. Treadway, E. T. Wick, et al. “The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP.J Biol Chem 298, no. 5 (May 2022): 101899. https://doi.org/10.1016/j.jbc.2022.101899.
Umano A, Fang K, Qu Z, Scaglione JB, Altinok S, Treadway CJ, et al. The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP. J Biol Chem. 2022 May;298(5):101899.
Umano, A., et al. “The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP.J Biol Chem, vol. 298, no. 5, May 2022, p. 101899. Pubmed, doi:10.1016/j.jbc.2022.101899.
Umano A, Fang K, Qu Z, Scaglione JB, Altinok S, Treadway CJ, Wick ET, Paulakonis E, Karunanayake C, Chou S, Bardakjian TM, Gonzalez-Alegre P, Page RC, Schisler JC, Brown NG, Yan D, Scaglione KM. The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP. J Biol Chem. 2022 May;298(5):101899.

Published In

J Biol Chem

DOI

EISSN

1083-351X

Publication Date

May 2022

Volume

298

Issue

5

Start / End Page

101899

Location

United States

Related Subject Headings

  • Ubiquitination
  • Ubiquitin-Protein Ligases
  • Ubiquitin
  • Spinocerebellar Ataxias
  • Mutation
  • Humans
  • Biochemistry & Molecular Biology
  • 34 Chemical sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences